肝脏脂肪的超声定量:过去、现在与未来
综述讨论脂肪肝的社会影响及CT、MRI定量肝脂肪的现状,重点回顾现有和新兴的超声定量技术。传统定性征象对中重度脂肪变可靠但对轻度脂肪变及细微变化不可靠;基于衰减、背散射和声速的定量生物标志物及多参数建模、射频包络分析、人工智能工具有望应用。
要点
- 传统超声定性征象对中重度脂肪变可靠,对轻度脂肪变分级及细微变化不可靠。
- 基于衰减、背散射和声速的标准化定量超声生物标志物是新兴方向。
- 多参数建模、射频包络分析和人工智能工具有望用于肝脂肪定量。
核心结论
- 脂肪肝全球患病率高且不断上升,需要准确、可重复、可及的无创技术检测和定量肝脂肪;超声因安全、广泛可用而适合作为筛查和监测工具,新兴定量超声生物标志物和人工智能工具有望应用。
研究设计与样本
- 综述;讨论脂肪肝的社会影响,总结CT和MRI定量肝脂肪的现状,并描述过去、现有和未来潜在的超声评估肝脂肪技术,对每种超声技术描述概念、测量方法、优势和局限性。
关键影像表现/征象
- 传统超声定性征象对中度和重度脂肪变表现良好,但对轻度脂肪变分级较不可靠。
- 传统超声定性征象可能不可靠地检测随时间发生的细微变化。
临床应用与阅片要点
- CT可在机会性筛查中发挥潜在作用。
- MRI质子密度脂肪分数对肝脂肪定量提供高准确度。
- 考虑到全球高患病率,CT和MRI可能不适合广泛筛查和监测。
- 超声是安全且广泛可用的模态,适合作为筛查和监测工具。
- 新兴定量超声生物标志物基于衰减、背散射和声速的标准化测量,具有应用前景。
局限性
- 传统超声定性征象对轻度脂肪变分级较不可靠,且可能不可靠地检测随时间发生的细微变化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Fatty liver disease has a high and increasing prevalence worldwide, is associated with adverse cardiovascular events and higher long-term medical costs, and may lead to liver-related morbidity and mortality. There is an urgent need for accurate, reproducible, accessible, and noninvasive techniques appropriate for detecting and quantifying liver fat in the general population and for monitoring treatment response in at-risk patients. CT may play a potential role in opportunistic screening, and MRI proton-density fat fraction provides high accuracy for liver fat quantification; however, these imaging modalities may not be suited for widespread screening and surveillance, given the high global prevalence. US, a safe and widely available modality, is well positioned as a screening and surveillance tool. Although well-established qualitative signs of liver fat perform well in moderate and severe steatosis, these signs are less reliable for grading mild steatosis and are likely unreliable for detecting subtle changes over time. New and emerging quantitative biomarkers of liver fat, such as those based on standardized measurements of attenuation, backscatter, and speed of sound, hold promise. Evolving techniques such as multiparametric modeling, radiofrequency envelope analysis, and artificial intelligence-based tools are also on the horizon. The authors discuss the societal impact of fatty liver disease, summarize the current state of liver fat quantification with CT and MRI, and describe past, currently available, and potential future US-based techniques for evaluating liver fat. For each US-based technique, they describe the concept, measurement method, advantages, and limitations. © RSNA, 2023 Online supplemental material is available for this article. Quiz questions for this article are available through the Online Learning Center.
引用
- Fetzer DT, Pierce TT, Robbin ML, et al. US Quantification of Liver Fat: Past, Present, and Future. Radiographics. 2023. PMID: 37289646. doi:10.1148/rg.220178
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。